glp 1 alzheimer's study High-stakes Novo Nordisk studies could yield answers on GLP-1 benefit GLP-1R agonists protect against Alzheimer's

Rapid fat loss, which Retatrutide delivers at a rate that exceeds most other approaches available to researchers, creates several tissue-level challenges

The proposed mechanisms are multifaceted

How can clinicians best support their patients taking GLP-1s to practically apply these nutrition and lifestyle interventions into their daily lives

A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain

Lack of insulin receptor signaling in Leprechaunism may result in the rare event of an alive but severely small for gestational age baby that will only survive if treated with recombinant-IGF-1 to substitute inulin receptor signaling with IGF1R signaling via their common intracellular pathways